688575，被证监会立案！2025年净利预计大降超90%

Core Viewpoint - The company YHLO (SH688575) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, following a previous warning from the Shanghai Stock Exchange regarding inaccurate disclosures related to a strategic cooperation agreement [1][3][4]. Group 1: Regulatory Actions - YHLO received a notice from the CSRC on February 6, indicating that the company is under investigation for alleged violations of information disclosure laws [1][3]. - The investigation stems from a January 7 announcement regarding a strategic cooperation framework with Shenzhen Brain Machine Starlink Technology Co., which was found to contain misleading statements [3][4]. - The Shanghai Stock Exchange had previously issued a warning to YHLO's then-Secretary of the Board for issues related to inaccurate and incomplete information disclosure [3][4]. Group 2: Financial Performance - YHLO's performance forecast for 2025 indicates a significant decline, with expected net profit attributable to shareholders dropping over 90% compared to the previous year [2][5]. - The projected net profit for 2025 is estimated to be between 20 million to 30 million yuan, down from approximately 300 million yuan in 2024, representing a decrease of 270 million to 280 million yuan [6]. - The decline in performance is attributed to industry policy impacts, reduced domestic market demand, and losses from trading financial assets [6]. Group 3: Business Operations - Despite domestic challenges, YHLO has reported stable growth in its international marketing business and progress in product development and industry layout [7]. - The company has achieved full coverage of the highest level (Class D) IVDR CE certification for its preoperative series of chemiluminescence testing reagents [7]. - The dual challenges of performance recovery and compliance rectification are critical for YHLO, with the market closely monitoring the company's progress in these areas [7].